In Reply I-Prescribing More Stringent Design of Randomized Clinical Trials of Omega-3 Polyunsaturated Fatty Acids

Affiliations

Comment

Dominik D Alexander. Mayo Clin Proc. 2017 Jun.

. 2017 Jun;92(6):1006-1007.

doi: 10.1016/j.mayocp.2017.04.003.

No abstract available

Comment on

A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk.
Alexander DD, Miller PE, Van Elswyk ME, Kuratko CN, Bylsma LC. Alexander DD, et al. Mayo Clin Proc. 2017 Jan;92(1):15-29. doi: 10.1016/j.mayocp.2016.10.018. Mayo Clin Proc. 2017. PMID: 28062061 Review.
Prescribing More Stringent Design of Randomized Clinical Trials of Omega-3 Polyunsaturated Fatty Acids.
McLennan PL, Pepe S. McLennan PL, et al. Mayo Clin Proc. 2017 Jun;92(6):1005-1006. doi: 10.1016/j.mayocp.2017.03.019. Mayo Clin Proc. 2017. PMID: 28578776 No abstract available.